Results 171 to 180 of about 107,669 (285)

Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins [PDF]

, 2017
Zhi-hao Xiang, Ruifeng Sun, Chen Lin, Fu-zeng Chen, Juntao Mai, Yuxiao Liu, Ziyan Xu, Lu Zhang, Jun Liu   +8 more
openalex   +1 more source

Vaccine confidence and potential implications for new tuberculosis vaccines. [PDF]

BMC Glob Public Health
Hesketh ZM, Clark RA, Limaye R, Pelzer PT, Palmer S, White RG.   +5 more
europepmc   +1 more source

Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China. [PDF]

BMC Med, 2022
Weerasuriya CK, Harris RC, McQuaid CF, Bozzani F, Ruan Y, Li R, Li T, Rade K, Rao R, Ginsberg AM, Gomez GB, White RG.   +11 more
europepmc   +1 more source

Guiding Questions for Focus Group Discussions on Health Care, Tuberculosis, and Acceptability of a New TB Vaccine among Incarcerated Individuals.

Mariana Cristina Campos Falleiros Pires (22857465), Yiran E. Liu (11450473), Everton Ferreira Lemos (11450476), Liliane Ferreira da Silva (9530180), Mariana Garcia Croda (11246224), Monica Magalhães (22857468), Dhélio Batista Pereira (7028753), Mariana Pinheiro Alves Vasconcelos (22857471), Rosilene Ruffato (3425549), Solana Monteiro Batista (22857474), Giselle Lima de Freitas (22857477), Marcelo Cordeiro-Santos (671984), Giane Zupellari dos Santos-Melo (22857480), Jair dos Santos Pinheiro (2224042), Lara B. O. Assis (22857483), Lia Gonçalves Possuelo (7394276), Tiago Antonio Heringer (22857486), Daiane Kist Back (22857489), Pauline Schwarzbold (14005795), Jason R. Andrews (7871738), Crhistinne Cavalheiro Maymone Gonçalves (10401861), Julio Croda (230548)   +21 more
openalex   +1 more source

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis

, 2011
Edward O. Ronan
openalex   +2 more sources

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial [PDF]

, 2018
Rhea N. Coler, Tracey A. Day, Ruth D. Ellis, Franco M. Piazza, Anna Marie Beckmann, Julie Vergara, Tom Rolf, Lenette L. Lu, Galit Alter, David A. Hokey, Lakshmi Jayashankar, Robert Walker, Margaret Ann Snowden, Tom Evans, Ann M. Ginsberg, Steven G. Reed, Jill A. Ashman, Zachary K. Sagawa, David L. Tait, Sadritdin Ishmukhamedov, Gretta Blatner, Sharon Egretta Sutton, Barbara Shepherd, Casey Johnson, Casey Johnson   +24 more
openalex   +1 more source

Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines. [PDF]

Cell
Vidal SJ, Lasrado N, Tostanoski LH, Chaudhari J, Mbiwan ER, Neka GD, Strutton EA, Espinosa Perez AA, Sellers D, Barrett J, Lifton M, Wakabayashi S, Eshaghi B, Borducchi EN, Aid M, Li W, Scriba TJ, Jaklenec A, Langer R, Barouch DH.   +19 more
europepmc   +1 more source

Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants. [PDF]

Cells, 2021
Franco AR, Peri F.
europepmc   +1 more source

Tuberculosis Vaccines and Prevention of Infection [PDF]

, 2014
Thomas R. Hawn, Tracey A. Day, Thomas J. Scriba, Mark Hatherill, Willem A. Hanekom, Thomas G. Evans, Gavin Churchyard, James G. Kublin, Linda‐Gail Bekker, Steven G. Self   +9 more
openalex   +1 more source

Tuberculosis Vaccines: Multidimensional Exploration and Breakthroughs from Innovative Design to Evaluation Systems. [PDF]

Vaccines (Basel)
Gong W, Aspatwar A.
europepmc   +1 more source